Decheng Capital Management Iii (Cayman), LLC Scynexis Inc Call Options Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Black Rock Inc. New York, NY424KShares$250,0050.0% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...